Article

Group establishes guidelines for drug studies of relapsed prostate Ca patients

A group of three leading cancer centers has developed guidelines to determine which prostate cancer patients at risk for relapse should participate in a clinical trial and which compounds are appropriate in these studies.

Related Videos
2 experts in this video
2 experts in this video
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.